These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20657837)

  • 21. Quinazoline derivative QPB-15e stabilizes the c-myc promoter G-quadruplex and inhibits tumor growth in vivo.
    Li Z; Liu C; Huang C; Meng X; Zhang L; He J; Li J
    Oncotarget; 2016 Jun; 7(23):34266-76. PubMed ID: 27144522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of THZif-1, a MAZ-like zinc finger protein to the nuclease-hypersensitive element in the promoter region of the c-MYC protooncogene.
    Sakatsume O; Tsutsui H; Wang Y; Gao H; Tang X; Yamauchi T; Murata T; Itakura K; Yokoyama KK
    J Biol Chem; 1996 Dec; 271(49):31322-33. PubMed ID: 8940139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of the major quadruplex formed in the promoter region of the human c-MYC oncogene.
    Stump S; Mou TC; Sprang SR; Natale NR; Beall HD
    PLoS One; 2018; 13(10):e0205584. PubMed ID: 30312328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of c-myc transcription by triple helix formation.
    Postel EH
    Ann N Y Acad Sci; 1992 Oct; 660():57-63. PubMed ID: 1340156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thermodynamics of i-tetraplex formation in the nuclease hypersensitive element of human c-myc promoter.
    Mathur V; Verma A; Maiti S; Chowdhury S
    Biochem Biophys Res Commun; 2004 Aug; 320(4):1220-7. PubMed ID: 15249220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A nuclease hypersensitive element in the human c-myc promoter adopts several distinct i-tetraplex structures.
    Simonsson T; Pribylova M; Vorlickova M
    Biochem Biophys Res Commun; 2000 Nov; 278(1):158-66. PubMed ID: 11071868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleic acid clamp-mediated recognition and stabilization of the physiologically relevant MYC promoter G-quadruplex.
    Hao T; Gaerig VC; Brooks TA
    Nucleic Acids Res; 2016 Dec; 44(22):11013-11023. PubMed ID: 27789698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between a Bioflavonoid and c-MYC Promoter G-Quadruplex DNA: Ensemble and Single-Molecule Investigations.
    Paul S; Hossain SS; M BD; Samanta A
    J Phys Chem B; 2019 Mar; 123(9):2022-2031. PubMed ID: 30758965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of a Family of Genomic Sequences Which Interact Specifically with the c-MYC Promoter to Regulate c-MYC Expression.
    Rezzoug F; Thomas SD; Rouchka EC; Miller DM
    PLoS One; 2016; 11(8):e0161588. PubMed ID: 27551915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C1orf35 contributes to tumorigenesis by activating c-MYC transcription in multiple myeloma.
    Luo SQ; Xiong DH; Li J; Li G; Wang Y; Zhang JM; Bu XF; Hu WX; Hu J
    Oncogene; 2020 Apr; 39(16):3354-3366. PubMed ID: 32103167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating actinomycin D binding to G-quadruplex, i-motif and double-stranded DNA in 27-nt segment of c-MYC gene promoter.
    Niknezhad Z; Hassani L; Norouzi D
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():1188-93. PubMed ID: 26478420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biophysical studies of the c-MYC NHE III1 promoter: model quadruplex interactions with a cationic porphyrin.
    Freyer MW; Buscaglia R; Kaplan K; Cashman D; Hurley LH; Lewis EA
    Biophys J; 2007 Mar; 92(6):2007-15. PubMed ID: 17172304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation of pseudosymmetrical G-quadruplex and i-motif structures in the proximal promoter region of the RET oncogene.
    Guo K; Pourpak A; Beetz-Rogers K; Gokhale V; Sun D; Hurley LH
    J Am Chem Soc; 2007 Aug; 129(33):10220-8. PubMed ID: 17672459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human MYC G-quadruplex: From discovery to a cancer therapeutic target.
    Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The c-MYC NHE III(1): function and regulation.
    González V; Hurley LH
    Annu Rev Pharmacol Toxicol; 2010; 50():111-29. PubMed ID: 19922264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triplex forming ability of a c-myc promoter element predicts promoter strength.
    Firulli AB; Maibenco DC; Kinniburgh AJ
    Arch Biochem Biophys; 1994 Apr; 310(1):236-42. PubMed ID: 8161210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intramolecular folding of a fragment of the cytosine-rich strand of telomeric DNA into an i-motif.
    Leroy JL; Guéron M; Mergny JL; Hélène C
    Nucleic Acids Res; 1994 May; 22(9):1600-6. PubMed ID: 8202359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A direct and nondestructive approach to determine the folding structure of the I-motif DNA secondary structure by NMR.
    Dai J; Ambrus A; Hurley LH; Yang D
    J Am Chem Soc; 2009 May; 131(17):6102-4. PubMed ID: 19400591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folding and hydrodynamics of a DNA i-motif from the c-MYC promoter determined by fluorescent cytidine analogs.
    Reilly SM; Lyons DF; Wingate SE; Wright RT; Correia JJ; Jameson DM; Wadkins RM
    Biophys J; 2014 Oct; 107(7):1703-11. PubMed ID: 25296324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastases suppressor NM23-H2 interaction with G-quadruplex DNA within c-MYC promoter nuclease hypersensitive element induces c-MYC expression.
    Thakur RK; Kumar P; Halder K; Verma A; Kar A; Parent JL; Basundra R; Kumar A; Chowdhury S
    Nucleic Acids Res; 2009 Jan; 37(1):172-83. PubMed ID: 19033359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.